Tirzepatide, a recently approved medication, is capturing significant attention within the healthcare community as a potential game-changer for individuals managing Adult-onset Metabolic Disorder. Unlike traditional diabetes therapies, tirzepatide functions by engaging two hormones : GLP-1 and GIP, leading to better blood sugar control and, in some